Back

Association of serum MMP9 with adverse features of plaque progression in patients with chronic coronary syndrome (CCS).

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Lesion characteristics in coronary artery disease Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Chiara Caselli

CNR – National Research Council, Pisa (Italy)

5 More presentations in this session

Presentation thumbnail
Misclassification rate of the angiographically identified culprit lesion in NSTEMI
Doctor K. Ekstroem (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Morphological and clinical implications of the optical coherence tomography-derived lipid core burden index.
Doctor F. Biccire (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Differences in microRNA expression in pericoronary tissue adjacent to atherosclerotic plaque and from lesion-free coronary artery
Doctor M. Marketou (Heraklion, GR)
Abstract Slides Video
Presentation thumbnail
Identification of coronary plaque rupture or erosion by preprocedural computed tomography angiography in patients with non-st-segment elevation acute coronary syndrome
Doctor T. Nagamine (Ibaraki, JP)
Abstract Slides Video
Presentation thumbnail
Heterogeneous plaque geometry is associated with major adverse cardiovascular events
Doctor Z. Gu (Cambridge, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Lesion characteristics in coronary artery disease

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Incremental prognostic value of coronary plaque features on CT angiography in symptomatic patients with obstructive CAD
thumbnail
Congress Presentation
Phenotyping coronary plaque by computed tomography in premature coronary artery disease.
thumbnail
Congress Presentation
The predictive value of matrix metalloproteinase-9 as an inflammation marker in anticipating adverse events one year after experiencing a st-elevation myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources